Shea Golonka
Family · Naples, FLNPI 1548076045
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $26.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$525
- Incyte Corporation$289
- Daiichi Sankyo Inc.$235
- Novartis$222
- Johnson & Johnson$192
- Pfizer$186
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,35694%
- Education$1966%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 17 | $525 |
| Incyte Corporation | 11 | $289 |
| Daiichi Sankyo Inc. | 9 | $235 |
| Novartis | 11 | $222 |
| Johnson & Johnson | 7 | $192 |
| Pfizer | 8 | $186 |
| Lilly USA, LLC | 3 | $167 |
| Merck | 5 | $142 |
| AbbVie | 3 | $123 |
| Sobi, Inc | 4 | $112 |
| Geron Corporation | 4 | $112 |
| Beone Medicines USA, Inc. | 5 | $111 |
| Bayer | 5 | $104 |
| GSK | 3 | $84 |
| Gilead | 3 | $82 |
| Genentech USA, Inc. | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $71 |
| Bristol Myers Squibb | 3 | $70 |
| Tersera Therapeutics LLC | 2 | $62 |
| Servier Pharmaceuticals LLC | 2 | $55 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| AVEO Pharmaceuticals, Inc. | 2 | $39 |
| Recordati_rare_diseases_inc. | 1 | $29 |
| Taiho Oncology, Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Array Biopharma Inc | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
How this compares
$3,552 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Naples
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.